ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 426 filers reported holding ENCOMPASS HEALTH CORP in Q1 2019. The put-call ratio across all filers is 2.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $467,000 | +7.4% | 8,326 | +24.9% | 0.02% | +13.3% |
| Q4 2021 | $435,000 | -58.7% | 6,666 | -52.5% | 0.02% | -55.9% |
| Q3 2021 | $1,052,000 | +3087.9% | 14,025 | +3184.5% | 0.03% | +3300.0% |
| Q2 2021 | $33,000 | -98.1% | 427 | -98.0% | 0.00% | -98.3% |
| Q1 2021 | $1,717,000 | +402.0% | 20,966 | +407.2% | 0.06% | +286.7% |
| Q4 2020 | $342,000 | -27.5% | 4,134 | -43.1% | 0.02% | -70.0% |
| Q3 2020 | $472,000 | -57.6% | 7,260 | -59.6% | 0.05% | -59.7% |
| Q2 2020 | $1,112,000 | +16.1% | 17,956 | +29.8% | 0.12% | -45.1% |
| Q4 2019 | $958,000 | +569.9% | 13,830 | +510.6% | 0.23% | +451.2% |
| Q3 2019 | $143,000 | -4.0% | 2,265 | -11.4% | 0.04% | -30.5% |
| Q1 2019 | $149,000 | +40.6% | 2,555 | +48.9% | 0.06% | +18.0% |
| Q4 2018 | $106,000 | -80.1% | 1,716 | -74.8% | 0.05% | -72.5% |
| Q3 2018 | $532,000 | +274.6% | 6,821 | +174.5% | 0.18% | +149.3% |
| Q1 2018 | $142,000 | – | 2,485 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |